Skip to main content
. 2022 Jun 7;21(19):2065–2078. doi: 10.1080/15384101.2022.2085356

Table 1.

The relationship between clinicopathologic factors and expression levels of SAMHD1 in patients with gastric cancer.

Factors SAMHD1
χ2/t P
Higher (n = 29) Lower (n = 29)
Gender Male 22 23 0.099 0.753
Female 7 6
Age (years)   61.00 ± 10.98 65.72 ± 9.25 1.774 0.082
Tumor size (cm)   4.11 ± 1.57 5.26 ± 2.09 2.357 0.022
Differential grade Well 19 16 0.648 0.421
Poor 10 13
T stage T1, T2 12 4 5.524 0.019
T3, T4 17 25
N stage N0 12 6 2.900 0.089
N1-3 17 23
TNM stage I 8 2 6.867 0.032
II 11 8
III 10 19
Perineural invasion Negative 8 5 0.892 0.345
Positive 21 24
LVIa Negative 10 4 3.390 0.066
Positive 19 25

alymphovascular invasion。